Novavax, Inc. is a global biotechnology company committed to helping address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.

Our mission

We never rest in our quest to protect the health of people everywhere.

Novavax is here to make a difference. We're a biotech company focused solely on developing life-saving vaccines to fight infectious diseases.

Our commitment is backed by solid science tested by decades of research, vaccines developed from trusted technology and a global network that will help to ensure our vaccines reach everyone who needs them.

Select local leaders
Olivia Chua
Olivia Chua
General Manager,
Commercial Operations,
Asia Pacific
Muruga Vadivale
Muruga Vadivale
Senior Director,
Medical Affairs,
Asia Pacific
Novavax worldwide

Novavax APAC
Novavax's APAC Commercial Operations is based in Singapore. 

Our Australia presence is located in Sydney, Australia, and together with New Zealand, we operate under a partnership with Biocelect. We also maintain strategic partnerships in the region with Serum Institute in India, SK bioscience in South Korea, and Takeda in Japan.

Novavax APAC map

Novavax Europe
Starting 2022, Novavax started to develop commercial hubs throughout Europe with the regional main office in Zurich, Switzerland. Additonal offices are now established also in Brussels, Belgium and Barcelona, Spain. Local manufacturing facilities are in Czech Republic and Sweden. 

Novavax office locations in Europe
General inquiries

+61 2 7202 1444
09:00 - 17:00 AEDT
Monday - Friday

Our location: 
Novavax, Inc.
700 Quince Orchard Road
Gaithersburg, MD 20878

Media contact
Investor contact

To contact a member of the investor relations team, click on the "Contact us" button below.